Gender differences in correlations among cardiovascular risk factors (Q51486315)

5 April 2018

title

Gender differences in correlations among cardiovascular risk factors (English)

1 reference

5 April 2018

author name string

Eiji Oda

1

1 reference

5 April 2018

Masahiro Abe

2

1 reference

5 April 2018

Kiminori Kato

3

1 reference

5 April 2018

Kenichi Watanabe

4

1 reference

5 April 2018

Punniyakoti T Veeraveedu

5

1 reference

5 April 2018

Yoshifusa Aizawa

6

1 reference

5 April 2018

publication date

1 September 2006

1 reference

5 April 2018

published in

Gender Medicine

1 reference

5 April 2018

volume

3

1 reference

5 April 2018

issue

3

1 reference

5 April 2018

page(s)

196-205

1 reference

5 April 2018

Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence

cites work

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

The association of metabolic disorders with the metabolic syndrome is different in men and women

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

The metabolic syndrome: more than the sum of its parts?

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Leptin: a novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Incidence of acute myocardial infarction in Takashima, Shiga, Japan

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations?

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Gender differences on the risk evaluation of acute coronary syndromes: the CARDIO2000 study

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Body mass index, diabetes, and C-reactive protein among U.S. adults

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population : Jichi Medical School Cohort Study

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: the Minoh Study

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Effects of gender, body composition, and menopause on plasma concentrations of leptin

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

A case-control pilot study on n-3 polyunsaturated fatty acid as a negative risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Is there a role for the ob gene product leptin in essential hypertension?

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Gender-dependent differences in plasma leptin in essential hypertension

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Gender-specific correlates of leptin with hypertension-related phenotypes in African Americans

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Gender difference in the relationships among hyperleptinemia, hyperinsulinemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Comparative analysis of plasma leptin levels in both genders of patients with essential hypertension and healthy subjects.

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

Leptin and the metabolic syndrome in Korean adolescents: factor analysis

1 reference

https://api.crossref.org/works/10.1016/S1550-8579(06)80208-1

7 January 2021

10.1016/S1550-8579(06)80208-1

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018